Enzyme- and Transporter-Based Drug-Drug Interactions: Progress and Future Challenges - Image 1

£146.53

Springer Enzyme- and Transporter-Based Drug-Drug Interactions: Progress and Future Challenges

Name: Enzyme- and Transporter-Based Drug-Drug Interactions: Progress and Future Challenges
Brand: Springer
Price: 146.53 GBP
Availability: InStock

Pharmacology

This is the usual price. Wait for it to drop, or tell us your number.

£147 today · usual range £0–£0 · best ever £137

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 613 days • 613 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 613 days • 7 price levels

Days at Price

Current Price

Price Analysis

Most common price: £137 (234 days, 38.2%)

Price range: £137 - £175

Price levels: 7 different prices over 613 days

Description

Germination of the thought of "Enzymatic- and Transporter-Based Drug-Drug Interactions: Progress and Future Challenges" Proceedings came about as part of the annual meeting of The American Association of Pharmaceutical Scientists (AAPS) that was held in San Diego in November of 2007. The attendance of workshop by more than 250 pharmaceutical scientists reflected the increased interest in the area of drug-drug interactions (DDIs), the greater focus of PhRMA, academia, and regulatory agencies, and the rapid pace of growth in knowledge. One of the aims of the workshop was to address the progress made in quantitatively predicting enzyme- and transporter-based DDIs as well as highlighted areas where such predictions are poor or areas that remain challenging for the future. Because of the serious clinical implications, initiatives have arisen from the FDA (http://www.fda.gov/cber/gdlns/interactstud.htm) to highlight the importance of enzyme- and transporter-based DDIs. During the past ten to fifteen years, we have come to realize that transporters, in addition to enzymes, play a vital role in drug elimination. Such insight has been possible because of the continued growth in PK-ADME (pharmacokinetics-absorption-distribution-metabolism-excretion) knowledge, fueled by further advances in molecular biology, greater availability of human tissues, and the development of additional and sophisticated model systems and sensitive assay methods for studying drug metabolism and transport in vitro and in vivo. This has sparked an in-depth probing into mechanisms surrounding DDIs, resulting from ligand-induced changes in nuclear receptors, as well as alterations in transporter and enzyme expression and function. Despite such advances, the in vitro and in vivo study of drug interactions and the integration of various data sets remain challenging. Therefore, it has become apparent that a proceeding that serves to encapsulate current strategies, approaches, methods and applications is necessary. As Editors, we have assembled a number of opinion leaders and asked them to contribute chapters surrounding these issues. Many of these are the original Workshop speakers whereas others had been selected specially to contribute on topics related to basic and applied information that had not been covered in other reference texts on DDI. The resulting tome, entitled Enzyme- and Transporter-Based Drug Interactions: Progress and Future Challenges, comprises of four sections. Twenty-eight chapters covering various topics and perspectives related to the subject of metabolic and transporter-based drug-drug interactions are presented.

Product Specifications

Brand: Springer
Format: Hardcover
ASIN: 1441908390
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Other Branches of Medicine > Pharmacology
Domain: Amazon UK
Release Date: 04 January 2010
Listed Since: 30 April 2009

Barcode

No barcode data available

Springer Enzyme- and Transporter-Based Drug-Drug Interactions: Progress and Future Challenges

This is the usual price. Wait for it to drop, or tell us your number.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Drug-Drug Interactions: 179 (Drugs and the Pharmaceutical Sciences)

Drug-Drug Interactions for Therapeutic Biologics

Drug-Drug Interactions

Mechanisms of Drug Interactions: 122 (Handbook of Experimental Pharmacology, 122)

Translating Molecules into Medicines: Cross-Functional Integration at the Drug Discovery-Development Interface: 25 (AAPS Advances in the Pharmaceutical Sciences Series, 25)

Humana Optimization in Drug Discovery: In Vitro Methods Book

Drug Metabolism: Current Concepts

Drug Information: A Guide for Pharmacists, Fourth Edition

Medicinal Chemistry: A Molecular and Biochemical Approach

Handbook of Drug-Nutrient Interactions (Nutrition and Health)

Drug Metabolism: Current Concepts

Integration of Pharmaceutical Discovery and Development: Case Histories: 11 (Pharmaceutical Biotechnology, 11)

Pharmazeutische/Medizinische Chemie: Arzneistoffe - von der Struktur zur Wirkung

Transporters and Drug-Metabolizing Enzymes in Drug Toxicity

Evaluation of Drug Candidates for Preclinical Development: Pharmacokinetics, Metabolism, Pharmaceutics, and Toxicology (Wiley Series in Drug Discovery and Development)

Basic Pharmacology: Understanding Drug Actions and Reactions (Pharmacy Education Series)

Designing Multi-Target Drugs: Rsc: Volume 21 (Drug Discovery Series)

Current Topics in Nonclinical Drug Development: Volume 2

Therapy of Viral Infections: 15 (Topics in Medicinal Chemistry, 15)

Drug Interactions in Infectious Diseases: Mechanisms and Models of Drug Interactions

Pharmaceutical Chemistry: Drugs and Their Biological Targets

Drug Metabolism in Diseases

The Organic Chemistry of Drug Design and Drug Action

Enzyme Inhibition in Drug Discovery and Development: The Good and the Bad